MHRA (UK)Original article
Guidance: Clinical trials: Phase 1, 14-Day Pilot Programme
RegulatoryPositive
AI Analysis
Summary
MHRA announces a Phase 1 pilot programme aimed at delivering first wave regulatory assessments within 14 calendar days for qualifying applications by end of 2026.
Clinical Trial Data
Phase
Phase 1
Outcome Details
Phase 1 pilot programme for accelerated regulatory assessment in 14 calendar days
Importance:3/10
Sentiment:
0.50
regulatory_guidanceclinical_trialsphase_1mhraaccelerated_assessment
Related Companies
Read the original article
Published by MHRA (UK) on August 17, 2026 8:00 AM